Biotech & AI drug discoveryNature Biotechnology

In vivo engineering of CAR natural killer cells for immunotherapy using ligand-directed lipid nanoparticles

A Nature Biotechnology paper reports using ligand-directed lipid nanoparticles to engineer CAR natural killer cells in vivo for immunotherapy. The supplied context does not include trial stage or outcome details.

AI summary · generated only from source feed metadata; consult original

Source published2026-10-13T00:00:00+00:00

Published here2026-10-15T02:34:02+00:00

Original source

Nature Biotechnology

Media report · consult original reporting

Read the original ↗https://www.nature.com/articles/s41587-026-03310-1

Original headline

In vivo engineering of CAR natural killer cells for immunotherapy using ligand-directed lipid nanoparticles

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.